BR9916318A - Compostos bicìclicos - Google Patents

Compostos bicìclicos

Info

Publication number
BR9916318A
BR9916318A BR9916318-7A BR9916318A BR9916318A BR 9916318 A BR9916318 A BR 9916318A BR 9916318 A BR9916318 A BR 9916318A BR 9916318 A BR9916318 A BR 9916318A
Authority
BR
Brazil
Prior art keywords
compounds
bicyclic compounds
bicyclical
myristoyltransferase
directed
Prior art date
Application number
BR9916318-7A
Other languages
English (en)
Inventor
Yuhko Aoki
Hirosato Ebiike
Toshihiko Fujii
Kenichi Kawasaki
Pingli Liu
Miyako Masubuchi
Tatsuo Ohtsuka
Shinji Tsujii
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of BR9916318A publication Critical patent/BR9916318A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Abstract

Patente de Invenção: <B>"COMPOSTOS BICìCLICOS"<D>. A presente invenção é direcionada aos novos compostos bicíclicos de fórmula [I], e seus sais farmaceuticamente aceitáveis, em que R^ 1^, R^ 2^, R^ 3^, R^ 4^, R^ 5^, R^ 6^, R^ 7^, Q^ 1^, Q^ 2^ e Q^ 3^ são conforme definidos nas reivindicações. Os compostos têm atividade inibitória de N-miristoiltransferase e antifungicida.
BR9916318-7A 1998-12-18 1999-12-10 Compostos bicìclicos BR9916318A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124120 1998-12-18
PCT/EP1999/009763 WO2000037464A2 (en) 1998-12-18 1999-12-10 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors

Publications (1)

Publication Number Publication Date
BR9916318A true BR9916318A (pt) 2001-08-14

Family

ID=8233179

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916318-7A BR9916318A (pt) 1998-12-18 1999-12-10 Compostos bicìclicos

Country Status (18)

Country Link
US (1) US6376491B1 (pt)
EP (1) EP1149094B1 (pt)
JP (1) JP3435404B2 (pt)
KR (1) KR20010081117A (pt)
CN (1) CN1333770A (pt)
AR (1) AR021714A1 (pt)
AT (1) ATE264855T1 (pt)
AU (1) AU754233B2 (pt)
BR (1) BR9916318A (pt)
CA (1) CA2355694A1 (pt)
DE (1) DE69916664T2 (pt)
DK (1) DK1149094T3 (pt)
ES (1) ES2217882T3 (pt)
MX (1) MXPA01006218A (pt)
PE (1) PE20001324A1 (pt)
TR (1) TR200101779T2 (pt)
WO (1) WO2000037464A2 (pt)
ZA (1) ZA200104410B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU777594B2 (en) * 1999-05-24 2004-10-21 Mitsubishi Pharma Corporation Phenoxypropylamine compounds
SE9902987D0 (sv) * 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
JP4042566B2 (ja) * 2000-11-27 2008-02-06 田辺三菱製薬株式会社 ピペリジン化合物およびその医薬用途
US7078541B2 (en) * 2002-02-07 2006-07-18 Galileo Pharmaceuticals, Inc. Benzofuran derivatives
US6653346B1 (en) * 2002-02-07 2003-11-25 Galileo Pharmaceuticals, Inc. Cytoprotective benzofuran derivatives
WO2006015279A1 (en) * 2004-07-28 2006-02-09 Neurogen Corporation Heterocyclic diamine compounds as ligands of the melanin concentrating hormone receptor useful for the treatment of obesity, diabetes, eating and sexual disorders
WO2007020936A1 (ja) * 2005-08-17 2007-02-22 Daiichi Sankyo Company, Limited 抗真菌作用二環性複素環化合物
US20090270496A1 (en) * 2007-05-03 2009-10-29 Courchesne William E Antifungal compounds
GB0815947D0 (en) 2008-09-02 2008-10-08 Univ Dundee Compounds
CA2739901A1 (en) 2008-10-17 2010-04-22 Akaal Pharma Pty Ltd S1p receptors modulators
ES2590904T3 (es) 2008-10-17 2016-11-24 Akaal Pharma Pty Ltd Moduladores de receptores de S1P y uso de los mismos
GB201120993D0 (en) 2011-12-06 2012-01-18 Imp Innovations Ltd Novel compounds and their use in therapy
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
CN107540725B (zh) * 2016-06-29 2020-04-07 孙青� 一种水溶性丹参酮ⅱa衍生物及其制备与应用
GB201820660D0 (en) 2018-12-19 2019-01-30 Imperial Innovations Ltd Cancer treatments
GB201820659D0 (en) 2018-12-19 2019-01-30 Imperial Innovations Ltd Novel compostions and their use in therapy
GB202014736D0 (en) 2020-09-18 2020-11-04 Imperial College Innovations Ltd Novel compounds and their use in therapy
GB202017367D0 (en) 2020-11-02 2020-12-16 Imperial College Innovations Ltd Novel use
WO2024052684A1 (en) 2022-09-09 2024-03-14 MyricX Pharma Limited Antibody drug conjugate comprising nmt inhibitor and its use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1129072A (en) * 1966-02-01 1968-10-02 Ici Ltd Benzofuran and indole derivatives
GB1256735A (pt) * 1969-03-06 1971-12-15
US3853923A (en) * 1971-05-13 1974-12-10 Kakenyaku Kako Kk 2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans
US4056626A (en) 1971-05-13 1977-11-01 Kakenyaku Kako Co., Ltd. Pharmaceutical composition containing benzofuran derivative
CA1089866A (en) * 1975-10-20 1980-11-18 Kiyoshi Ito Benzofuran derivatives, preparation thereof and pharmaceutical compositions thereof
SU671256A1 (ru) * 1977-06-08 1986-11-23 Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе Гидрохлорид 1-(2-карбэтокси-3-метилбензофуран-4-илокси-3-изопропиламино)-2-пропанола,обладающий антиаритмическим и @ -адреноблокирующим действием
JPS5740479A (en) * 1980-08-21 1982-03-06 Kaken Pharmaceut Co Ltd Preparation of benzofuran derivative and its acid addition salt
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
US5082967A (en) * 1988-06-16 1992-01-21 Washington University Novel fatty acid analog enzyme substrates
FR2672598A1 (fr) * 1991-02-11 1992-08-14 Adir Nouveaux inhibiteurs de n-myristoyltransferase, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07215940A (ja) * 1994-01-27 1995-08-15 Torii Yakuhin Kk 抗ウイルス活性を有する化合物
JPH08198826A (ja) * 1995-01-23 1996-08-06 Torii Yakuhin Kk 抗ウイルス活性を有する化合物

Also Published As

Publication number Publication date
DK1149094T3 (da) 2004-08-16
AR021714A1 (es) 2002-07-31
CA2355694A1 (en) 2000-06-29
KR20010081117A (ko) 2001-08-27
US6376491B1 (en) 2002-04-23
AU754233B2 (en) 2002-11-07
ATE264855T1 (de) 2004-05-15
DE69916664T2 (de) 2005-03-31
PE20001324A1 (es) 2000-12-02
WO2000037464A3 (en) 2000-11-02
EP1149094B1 (en) 2004-04-21
JP3435404B2 (ja) 2003-08-11
DE69916664D1 (de) 2004-05-27
CN1333770A (zh) 2002-01-30
WO2000037464A2 (en) 2000-06-29
ZA200104410B (en) 2002-08-29
MXPA01006218A (es) 2002-04-17
EP1149094A2 (en) 2001-10-31
JP2002533340A (ja) 2002-10-08
AU2660600A (en) 2000-07-12
TR200101779T2 (tr) 2001-12-21
ES2217882T3 (es) 2004-11-01

Similar Documents

Publication Publication Date Title
BR9916318A (pt) Compostos bicìclicos
BR9812010A (pt) Determinados ácidos 5-alquil-2-arilaminofenilacéticos e derivados
TR199902606T2 (xx) Farnesil transferaz� engelleyici kinazolinonlar.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AU9309898A (en) Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
BG66085B1 (bg) Фенилаланинови производни
BR9708632A (pt) Composto calcilìticos
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
BR0109703A (pt) Derivados de piperazina
BRPI0014076B8 (pt) benzamidas e inibidores correlatos do fator xa
BR0210445A (pt) Derivados de n-fenilpirrol guanidina como ligandos de receptor melanocortin
BRPI0412291A (pt) antagonistas duplos de nka/nk3 para o tratamento de esquizofrenia
BR0108678A (pt) Novos compostos
BR9810021A (pt) Derivados 9-oxima-eritromicina
BR9800884A (pt) Aplicação de derivados de pirimidina para a prevenção do câncer, por si só ou em combinação com outras medidas terapêuticas.
BR0110998A (pt) Derivados de fenilglicina
TR200102489T2 (tr) 3-Fenilpiridin Türevleri ve bunların NK-1 alıcı antagonistler olarak kullanılması
TR199900486T2 (xx) Aziniloksi ve fenoksi-diaril-karbonasit t�revleri.
BR0210531A (pt) Derivados de ácido sulfÈnico
BR9910908A (pt) Indenopirrolocarbazóis ligados em ponte
YU52000A (sh) Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina
TR200200263T2 (tr) Yeni seçiçi retinoid agonistleri
BR9812922A (pt) Isoquinolinas como inibidores de uroquinase
NO995114L (no) Festeanordning for å forbinde to deler med hverandre, samt anvendelse av festeanordningen
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O E 7O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.